Author/Creator: Nagasaka, Yasuhisa - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Nagasaka, Yasuhisa

1. Application of a physiologically based pharmacokinetic model for the prediction of mirabegron plasma concentrations in a population with severe renal impairment. (27th May 2019)

Authors:: Konishi, Kentaro; Minematsu, Tsuyoshi; Nagasaka, Yasuhisa; Tabata, Kenji
Journal:: Biopharmaceutics & drug disposition
Issue:: Volume 40:Number 5/6(2019:May/Jun.)
Page Start:: 176
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Human mass balance, metabolite profile and identification of metabolic enzymes of [14C]ASP015K, a novel oral janus kinase inhibitor. (October 2015)

Authors:: Oda, Kazuo; Cao, Ying J.; Sawamoto, Taiji; Nakada, Naoyuki; Fisniku, Ogert; Nagasaka, Yasuhisa; Sohda, Kin-ya
Journal:: Xenobiotica
Issue:: Volume 45:Number 10(2015:Oct.)
Page Start:: 887
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Impact of genetic deficiencies of P-glycoprotein and breast cancer resistance protein on pharmacokinetics of aripiprazole and dehydroaripiprazole. (October 2014)

Authors:: Nagasaka, Yasuhisa; Sano, Tomokazu; Oda, Kazuo; Kawamura, Akio; Usui, Takashi
Journal:: Xenobiotica
Issue:: Volume 44:Number 10(2014:Oct.)
Page Start:: 926
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. In vitro experimental system for evaluating inhibitory effect of investigational drugs on P‐glycoprotein‐mediated transcellular transport of tacrolimus (FK506). (19th November 2013)

Authors:: Oda, Kazuo; Nemoto, Hiroyuki; Nagasaka, Yasuhisa; Kawamura, Akio; Usui, Takashi
Journal:: Biopharmaceutics & drug disposition
Issue:: Volume 35:Number 3(2014:Apr.)
Page Start:: 135
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. In vitro/in vivo investigations to examine the gender differences in the pharmacokinetics of novel oral Janus kinase (JAK) inhibitor ASP015K and sulfate metabolite M2 in rats. (June 2015)

Authors:: Oda, Kazuo; Nakada, Naoyuki; Nagasaka, Yasuhisa
Journal:: Xenobiotica
Issue:: Volume 45:Number 6(2015:Jun.)
Page Start:: 488
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Physiologically-based pharmacokinetic modeling for mirabegron: a multi-elimination pathway mediated by cytochrome P450 3A4, uridine 5'-diphosphate-glucuronosyltransferase 2B7, and butyrylcholinesterase. (3rd August 2019)

Authors:: Konishi, Kentaro; Minematsu, Tsuyoshi; Nagasaka, Yasuhisa; Tabata, Kenji
Journal:: Xenobiotica
Issue:: Volume 49:Number 8(2019:Aug.)
Page Start:: 912
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Simultaneous determination of a novel oral Janus kinase inhibitor ASP015K and its sulfated metabolite in rat plasma using LC‐MS/MS. (7th November 2014)

Authors:: Oda, Kazuo; Mera, Katsumi; Nagasaka, Yasuhisa; Tokoro, Kazumi
Journal:: Biomedical chromatography
Issue:: Volume 29:Number 7(2015:Jul.)
Page Start:: 967
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer. (26th June 2021)

Authors:: Sayama, Hiroyuki; Marcantonio, Diana; Nagashima, Takeyuki; Shimazaki, Masashi; Minematsu, Tsuyoshi; Apgar, Joshua F; Burke, John M.; Wille, Lucia; Nagasaka, Yasuhisa; Kirouac, Daniel C.
Journal:: CPT: pharmacometrics & systems pharmacology
Issue:: Volume 10:Number 8(2021)
Page Start:: 864
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗